Client: Pergament & Cepeda LLP (USA)
Patent Applicant: Aizant Drug Research Solutions Pvt. Ltd. (India) — pharmaceutical company specializing in R&D and drug formulation
Legal Support Area: National phase entry of a PCT patent application in Ukraine
Project Summary
Polikarpov Law Firm represents Aizant Drug Research Solutions Pvt. Ltd. in Ukraine in connection with the national phase entry of the PCT application titled “Solid dosage forms of palbociclib” — a formulation used in oncology. The project is handled in coordination with the US law firm Pergament & Cepeda LLP, acting as the global legal counsel.
Client’s Goals
- Timely file the patent application in Ukraine under the PCT system
- Secure patent protection for palbociclib solid dosage technology
- Integrate Ukraine into the client’s global IP portfolio
Project Complexity
- Technical nature of the pharmaceutical invention
- Ensuring accurate and compliant translation under Ukrainian patent law
- Meeting formal deadlines for national phase entry
Polikarpov Law Firm’s Actions
- Reviewed the international application and translated relevant documents
- Prepared and submitted the Ukrainian national phase application in February 2023
- Maintained communication with the Ukrainian IP Office (UANIPIO) during examination
- Represented the client at all stages of the registration process
Lawyers
Anton Polikarpov — Managing Partner, coordinated with foreign counsel and led the project
Anastasiia Shevchuk — Senior Associate, handled document preparation and communication with UANIPIO
Result
The patent application “Solid dosage forms of palbociclib” was successfully filed in Ukraine in February 2023 and is currently undergoing examination. Polikarpov Law Firm continues to manage the process through to registration.
